Keung Laboratory
Emily Keung, M.D., F.A.C.S.
Principal Investigator
- Departments, Labs and Institutes
- Labs
- Keung Laboratory
Areas of Research
- B Cell Biology
- Cancer Biology
- Cancer Metastasis
- Genomics
- Immunotherapy
- Mouse Model Development
- Sarcoma
- Tumor Microenvironment
The Keung Laboratory seeks to understand the molecular pathogenesis and immuno-oncology of soft tissue sarcomas. Our goal is to identify novel therapeutic targets and treatment strategies and to translate these into the clinic to improve outcomes for our patients with these challenging cancers.
We're hiring!
Interested in joining the Keung Lab?
Recent Publications
Roland CL, Nassif Haddad EF, Keung EZ, et al. A randomized, non-comparative Phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature Cancer. 2024;5(4):6255-641.
Keung EZ, Burgess M, Salazar R, et al. Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab. Clinical Cancer Research. 2020;26(6):1258-1266.
Petitprez F, de Reyniès A, Keung EZ, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577(7791):556-560.
Funding Support
Society of Surgical Oncology Clinical Investigator Award
Society of University Surgeons Early-Stage Investigator Award
MD Anderson Physician Scientist Program
Leiomyosarcoma SPORE Developmental Research Program
Society for the Immunotherapy of Cancer Steven A. Rosenberg Scholar Award
National Cancer Institute Early-Stage Surgeon Scientist Program